Authors:
Hovorka, R
Albarrak, A
Chassin, L
Luzio, SD
Playle, R
Owens, DR
Citation: R. Hovorka et al., Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting Type 2 diabetes, DIABET MED, 18(10), 2001, pp. 797-802
Citation: Sd. Luzio et al., Effects of timing of administration and meal composition on the pharmacokinetic and pharmacodynamic characteristics of the short-acting oral hypoglycemic agent nateglinide in healthy subjects, J CLIN END, 86(10), 2001, pp. 4874-4880
Authors:
Owens, DR
Coates, PA
Luzio, SD
Tinbergen, JP
Kurzhals, R
Citation: Dr. Owens et al., Pharmacokinetics of I-125-labeled insulin glargine (HOE 901) in healthy men - Comparison with NPH insulin and the influence of different subcutaneousinjection sites, DIABET CARE, 23(6), 2000, pp. 813-819
Citation: Dr. Owens et al., Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes, DIABET CARE, 23(4), 2000, pp. 518-523
Authors:
Ollerton, RL
Playle, R
Luzio, SD
Owens, DR
Citation: Rl. Ollerton et al., Underdiagnosis of type 2 diabetes by use of American Diabetes Association criteria, DIABET CARE, 22(4), 1999, pp. 649-650
Authors:
Ollerton, RL
Playle, R
Ahmed, K
Dunstan, FD
Luzio, SD
Owens, DR
Citation: Rl. Ollerton et al., Day-to-day variability of fasting plasma glucose in newly diagnosed type 3diabetic subjects, DIABET CARE, 22(3), 1999, pp. 394-398